Michael V Pishko

Austin, TX, United States of America

Michael V Pishko

This inventor holds 25 USPTO granted patents and 19 published patent applications, primarily in Glucose Monitoring. Top assignees: E. Heller & Company, Abbott Diabetes Care Inc., Therasense, Inc.. Active years: 1993-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael V Pishko. Retrieved from https://idiyas.com/inventor/michael-v-pishko

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 25 

% Patents Active = 64.0

Average Co-Inventor Count = 2.7

ph-index = 20

Forward Citations = 17,475(Granted Patents)


Location History:

  • Arlington, MA (US) (1999)
  • Bryan, TX (US) (2001 - 2002)
  • College Station, TX (US) (2002)
  • State College, PA (US) (2010 - 2012)
  • Austin, TX (US) (1993 - 2014)

Company Filing History:


Years Active: 1993-2014

Loading Chart...
Areas of Expertise:
Subcutaneous Glucose Electrode
Fluorescence Quenching
Implantable Systems
Transdermal Transport
Electrochemical Measurement
Analyte Detection
Photocatalyst-Binder Compositions
Enzyme Electrodes
Chemical Enhancers
Ultrasound Techniques
25 patents (USPTO):Explore Patents

Title: **Michael V Pishko: A Pioneer in Glucose Monitoring Technology**

Introduction

Michael V Pishko, based in Austin, TX, is an esteemed inventor known for his significant contributions to the field of biomedical engineering. With a remarkable portfolio of 20 patents, his innovative work primarily focuses on the development of advanced glucose monitoring technologies that hold great promise for diabetes management.

Latest Patents

Among his latest inventions is the subcutaneous glucose electrode, which is a small diameter flexible electrode designed for subcutaneous in vivo amperometric monitoring of glucose. This electrode introduces a one-point in vivo calibration feature that ensures a zero output current at zero glucose concentration, even in the presence of other electroreactive species found in serum or blood. The electrode design comprises multiple layers, finely layered with a first glucose concentration-to-current transducing layer, followed by an electrically insulating and glucose flux limiting layer, an optional interference-eliminating horseradish peroxidase based film, and a final outer layer that is biocompatible.

Career Highlights

Michael has worked with notable companies in his career, including E. Heller & Company, where he honed his innovative skills and contributed to the advancement of medical technology. His experience in these organizations has fostered a robust understanding of the complex needs in the realm of biomedical applications.

Collaborations

Throughout his career, Michael has collaborated with esteemed professionals such as Adam Heller and Ephraim Heller. These partnerships have enabled the convergence of ideas and expertise, leading to the development of cutting-edge technologies in glucose monitoring.

Conclusion

Michael V Pishko stands out as a dedicated inventor in the field of glucose monitoring technology. His innovative spirit and contributions through multiple patents underscore his commitment to improving healthcare solutions for diabetes patients, paving the way for enhanced and more reliable monitoring methods.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…